Sunday, June 26, 2022
  • Login
CEO North America
  • Home
  • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
    • Environment
  • Opinion
  • News
  • Multimedia
No Result
View All Result
  • Home
  • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
    • Environment
  • Opinion
  • News
  • Multimedia
No Result
View All Result
CEO North America
No Result
View All Result

When Flu Season and COVID-19 Collide

in Health
Opec+ sticks to production growth plan
Share on FacebookShare on Twitter

Unprecedented. It’s the word that many people have used to define the past year and a half, and one that also reflects a number of “firsts” across many industries. This undoubtedly rings true for the team that oversees McKesson’s seasonal flu vaccine program.

During last year’s flu season (2020-2021), McKesson sent roughly 19% more doses of flu vaccines to customers throughout the U.S. than it did the previous season.

That’s more than the company – the country’s largest distributor of seasonal flu vaccines – has ever distributed throughout any given season in its history.

“Even in the season immediately following the H1N1 flu pandemic in 2009, we didn’t send that many seasonal flu doses,” says Omar Bateh, director of vaccines, McKesson Medical-Surgical. “This was a new record.”

It’s a feat that certainly wasn’t part of McKesson’s original plan going into last year. But then COVID-19 hit.

Planning for the Unplanned

No two flu seasons are alike. As flu strains mutate year over year, so too do infection rates, severity, vaccine efficacy and, consequently, the number of vaccines needed throughout the country.

“We have this saying in the industry – ‘If you’ve seen one flu season, you’ve seen one flu season,” quips Jon Schwarze, director of vaccines, Pharmaceutical Solutions and Services, McKesson. “Every flu season brings something different. We have our processes, but it really boils down to being agile and ready to handle whatever happens. That’s never been truer than it is this year.”

Every spring, McKesson begins the process of negotiating distribution agreements with vaccine manufacturers. These agreements culminate from months of close planning that starts with manufacturers, who begin the year with a baseline number of vaccines they plan to develop. McKesson then works with its customers – hospitals, physicians’ offices and retail pharmacies – to pre-book the number of vaccines they plan to administer for the upcoming season. By March of 2020, McKesson had already completed this part of the process and was prepared to distribute a similar number of doses as it did during the previous one.

But then COVID-19 began spreading through the country the same month. Faced with the threat of flu season and COVID-19 combining to create a “twindemic,” McKesson realized it needed to re-evaluate the number of doses its customers would require to help protect people throughout what could have been an extremely challenging respiratory season.

With the possibility of higher demand, avoiding a vaccine shortage meant McKesson had to go back to the drawing board with manufacturers and customers – and fast.

“Manufacturers can’t just flip the switch and start making more flu vaccines when demand changes,” Bateh explains. “Typically, it takes them about seven to eight months to grow, fill and finish a flu vaccine, and then also get FDA approval on that lot before it can be released for distribution.”

The McKesson team contacted its customers to communicate these unforeseen variables potentially impacting their success in the season ahead. As a result, additional pre-booking demand for flu vaccines in the U.S. market went up significantly. For retail pharmacy customers, requests soared.

“We have this saying in the industry – ‘If you’ve seen one flu season, you’ve seen one flu season.’ […] That’s never been truer than it is this year.”

To meet this surge in demand, McKesson went back to the manufacturers and the Centers for Disease Control and Prevention (CDC) to forecast how many additional vaccines needed to be produced. It also evaluated the timetable to deliver them once ready – an event that usually happens between July and September each year. With additional lots potentially not ready until November or December of 2020, McKesson needed to account for not only an extended distribution timeline to continue supporting demand throughout the season, but also the possibility that the COVID-19 pandemic could directly impact where those doses would be most needed.

Historically, the majority of patients get their flu shot during annual check-ups at their doctor’s office. With social distancing measures in place, however, Schwarze and Bateh anticipated those typical behaviors could change as well.

“In the event we experienced a spike in COVID-19 cases last flu season, we knew people might not go to their physicians’ offices for a routine visit, meaning they wouldn’t be getting vaccinated there,” Bateh says. “But they might still go to a retail location or a local pharmacy to get their flu shot. So we were closely monitoring our inventory in case we needed to shift doses across our supply chains to make sure they were going to the appropriate place at the appropriate time.”

Schwarze added that his team has always utilized an inventory sequestration tool that’s integrated across all McKesson distribution centers. As potential customer supply needs arise, McKesson can move any unused flu vaccines across the supply chain to those who need it.

Delivering Success in a Time of Disruption

As Bateh and Schwarze had anticipated, pharmacies handled a surge in vaccinations during the 2020-2021 season. By the first week of October alone, they had experienced a 72% increase in vaccinations over the same time in 2019, according to October 2020 IQVIA data. And McKesson’s teams continued to meet this record demand all season long – a testament to their ability to mobilize when plans change.

The CDC recently announced the beginning of the U.S.’ 2021-2022 flu season. And while last season fortunately turned out to be an extremely mild one, experts are being particularly vocal on the importance of getting vaccinated this season, which they predict to be much more severe.

For its part, McKesson is on track to meet the new demands of the current season. That’s because in a time of virtually no constants, the two that have carried McKesson’s flu vaccine team to success in the past are the same that have helped them do so throughout two flu seasons during COVID-19 – a versatile and adaptive supply chain, and continuous communication with customers, with industry partners, and with each other throughout every step of the process.

“You might think that because of COVID-19 we’re doing things very differently,” says Schwarze. “But from an operational standpoint, we’re doing it the same way we always have – leveraging everything that our supply chain and team of experts can offer so we can help our customers succeed during flu season – pandemic or not.”

Tags: CollideCOVID-19Fluflu seasonMcKessonSeason

Related Posts

The intersection of women’s history and school meal programs
Health

The Intersection of Women’s History and School Meal Programs

Overcoming the threats to global food systems from russia’s invasion of ukraine
Health

Overcoming the Threats to Global Food Systems from Russia’s Invasion of Ukraine

Usda: creating better vaccines
Food

USDA: Creating Better Vaccines

Floral hemp: from the field and greenhouse to cbd
Food

Floral Hemp: From the Field and Greenhouse to CBD

10 fitness blogs you should follow in 2022
Health

10 Fitness blogs you should follow in 2022

The best places to get relationship advice in 2022
Health

The best places to get relationship advice in 2022

The 4 relationships trends for dating apps in 2022
Health

The 4 relationships trends for dating apps in 2022

Virtual reality up, traditional tv down: pwc
Health

The Fourth Trimester and Beyond: The Case for Transformative Investments and Solutions in Maternal and Child Health

Amerisourcebergen begins investing in j. P. Morgan’s empower share class to support minority-owned & diverse-led financial institutions
Health

AmerisourceBergen Begins Investing in J.P. Morgan’s Empower Share Class to Support Minority-Owned & Diverse-Led Financial Institutions

Amerisourcebergen begins investing in j. P. Morgan’s empower share class to support minority-owned & diverse-led financial institutions
Health

Coronavirus Travel Information and Resources for New York

No Result
View All Result

Recent Posts

  • Smart Cities, Smarter Public Health
  • U.S. Consumer Sentiment Falls to Record Low
  • Hackers Steal $100 Million Worth in Latest Crypto Heist
  • Elon Musk is Worried About Tesla’s Possible Bankruptcy
  • Standing Still Is Not an Option

Recent Comments

    Archives

    Categories

    • Art & Culture
    • Business
    • CEO Interviews
    • CEO Life
    • Editor´s Choice
    • Entrepreneur
    • Environment
    • Food
    • Health
    • Highlights
    • Industry
    • Innovation
    • Issues
    • Management & Leadership
    • Multimedia
    • News
    • Opinion
    • PrimeZone
    • Printed Version
    • Travel
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    CEO Latin America | ES

    • CONTACT
    • GENERAL ENQUIRIES
    • ADVERTISING
    • MEDIA KIT
    • DIRECTORY
    • TERMS AND CONDITIONS

     

    AUSTIN

    600, Congress Avenue 14th Floor
    Austin, TX.
    78701
    USA
    +1 512 649 0340

    NEW YORK

    387 Park Ave South,
    New York, NY.
    10016
    USA
    +1 212 796 64 15

    CEO North America © 2022 - Sitemap

    No Result
    View All Result
    • Home
    • Business
      • Entrepreneur
      • Industry
      • Innovation
      • Management & Leadership
    • CEO Interviews
    • CEO Life
      • Art & Culture
      • Food
      • Health
      • Travel
      • Environment
    • Opinion
    • News
    • Multimedia

    © 2022 JNews - Premium WordPress news & magazine theme by Jegtheme.

    Welcome Back!

    Login to your account below

    Forgotten Password?

    Retrieve your password

    Please enter your username or email address to reset your password.

    Log In
    Are you sure want to unlock this post?
    Unlock left : 0
    Are you sure want to cancel subscription?